When you consume cannabis, your body only absorbs a percentage of the THC or CBD you take in. This absorption rate, called bioavailability, explains why a 100mg edible feels different from vaping the same amount of cannabis. The consumption method you choose directly affects how much reaches your bloodstream and how quickly you feel the effects.
Different delivery methods produce dramatically different absorption rates. Smoking cannabis delivers about 30% of its THC content to your system, while edibles may only provide 6-20%. Understanding these differences helps you dose more accurately and choose the right method for your needs.
Cannabis bioavailability measures the percentage of cannabinoids that actually enter your bloodstream after consumption. If you take a 100mg THC edible with 15% bioavailability, only 15mg reaches your system to produce effects. The remaining 85mg gets filtered out by your digestive system and liver before it can affect you.
Several factors influence how efficiently your body absorbs cannabis. Your metabolism, body weight, and tolerance all play a role. The presence of food in your stomach affects edible absorption, while lung capacity impacts inhalation methods. Individual enzyme activity also varies, which explains why the same dose affects people differently.
Your body processes different cannabinoids through distinct pathways, and THC and CBD follow separate absorption routes with their own bioavailability profiles. This is why CBD-dominant products often require higher doses to achieve noticeable effects compared to THC products.
Each consumption method delivers cannabis through a different biological pathway, resulting in unique absorption rates and onset times. Here’s how the most common methods compare:
| Method | Absorption Rate | Onset Time | Duration |
| Smoking | 30% | 2-5 minutes | 1-3 hours |
| Vaping | 56% | 2-5 minutes | 1-3 hours |
| Sublingual | 35% | 15-45 minutes | 2-4 hours |
| Edibles | 6-20% | 30-120 minutes | 4-8 hours |
| Topicals | Minimal systemic | 15-30 minutes | 2-6 hours |
Inhalation methods achieve the highest bioavailability because cannabinoids enter your bloodstream directly through lung tissue. The decarboxylation process occurs instantly when you apply heat, converting THCA into active THC.
Vaping delivers higher absorption rates than smoking because it heats cannabis to the optimal temperature range without combustion. This preserves more cannabinoids and reduces the harsh compounds that smoking produces. The controlled temperature also ensures more complete decarboxylation of the plant material.
Oral consumption produces the lowest bioavailability due to first-pass metabolism. Your digestive system breaks down cannabinoids before they reach your bloodstream, and your liver converts much of the remaining THC into different metabolites. However, research on oral cannabis bioavailability shows that taking edibles with fatty foods can improve absorption rates significantly.
The way cannabis affects you depends on more than just how much enters your system. The route of administration changes which metabolites your body produces and how long they remain active. This explains why 10mg from an edible feels completely different from 10mg inhaled through vaping.
When you smoke or vape cannabis, THC travels directly from your lungs to your brain within minutes. This rapid onset allows you to gauge effects quickly and adjust your dose accordingly. The high peaks within 30 minutes and gradually decreases over the next few hours.
Edibles take longer because THC must pass through your digestive system and liver first. During this first-pass metabolism, your liver converts THC into 11-hydroxy-THC metabolite, which produces more intense psychoactive effects than regular THC. This metabolite crosses the blood-brain barrier more efficiently, creating the characteristic “body high” that edible users describe.
Sublingual absorption offers a middle ground between inhalation and oral consumption. Cannabinoids absorb through the mucous membranes under your tongue, bypassing first-pass metabolism for the portion that enters your bloodstream directly. The remaining amount that you swallow follows the slower edible pathway, creating a dual-phase effect profile.
Choosing the right consumption method depends on your goals, lifestyle, and medical needs. Each delivery route offers distinct advantages for different situations and user preferences.
For immediate relief, inhalation methods provide the fastest onset and most predictable dosing. You can feel effects within minutes and easily adjust your intake based on how you respond. This makes smoking and vaping ideal for breakthrough pain, acute anxiety, or social situations where you need quick control over your cannabis experience.
Medical patients often benefit from combining multiple delivery methods throughout the day. A morning tincture provides baseline symptom management, while a vaporizer offers quick relief for breakthrough symptoms. This approach, called “layering,” allows for more consistent therapeutic effects.
THC absorption through skin remains minimal for most topical products, making them suitable for localized treatment without psychoactive effects. However, transdermal patches and specialized formulations can deliver cannabinoids systemically through enhanced penetration methods.
Cannabis companies have developed several technologies to improve bioavailability and create more predictable effects. These innovations address the traditional limitations of oral cannabis consumption, particularly the low absorption rates and delayed onset times.
Nano-emulsion technology breaks cannabinoids down into microscopic particles that dissolve more readily in water. This increased surface area allows for faster absorption in your digestive tract, reducing onset times from 1-2 hours to 15-30 minutes for some products. The smaller particle size also improves bioavailability by making cannabinoids more accessible to your body’s absorption mechanisms.
Liposomal encapsulation wraps cannabinoids in protective lipid layers that help them survive the acidic environment of your stomach. These formulations can bypass some first-pass metabolism and deliver cannabinoids more efficiently to your bloodstream. Research on liposomal cannabis delivery suggests these methods can double or triple the bioavailability of traditional edibles.
Some manufacturers use cyclodextrin complexes to improve cannabinoid solubility and stability. This technology creates molecular “cages” that protect cannabinoids during digestion and release them gradually for extended effects. While these advanced formulations often cost more than traditional products, they offer more consistent dosing and improved therapeutic outcomes for medical users.
Ready to explore medical cannabis options that match your individual needs and consumption preferences? Find a qualified physician who can help you determine the most effective delivery methods for your condition and lifestyle.
Note: The content on this page is for informational purposes only and is not intended to be professional medical advice. Do not attempt to self-diagnose or prescribe treatment based on the information provided. Always consult a physician before making any decision on the treatment of a medical condition.
Note: Veriheal does not support illegally consuming therapeutic substances such as cannabis but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.
Edibles produce 11-hydroxy-THC in your liver, which is more potent than regular THC and creates stronger psychoactive effects.
Wait at least 2 hours for edibles, 15 minutes for sublingual products, and 5-10 minutes between inhalation sessions.
Taking edibles with fatty foods like nuts or avocado can increase absorption by helping cannabinoids dissolve more effectively.
The consumption method affects bioavailability more than strain genetics, though terpenes may influence how cannabinoids interact with your body.
Most topicals don’t penetrate deep enough to reach your bloodstream in significant amounts, so they provide localized effects without psychoactive responses.
1. Absorption – a complete guide. Cannify. (2021). Retrieved December 7, 2021, from https://www.cannify.us/education/cannabis-and-the-body/cannabinoid-clinical-pharmacology/what-your-body-does-to-cannabis-pharmacokinetics/thc-absorption/
2. Fugh-Berman, A., Wood, S., Kogan, M., Abrams, D., Mathre, M. L., Robie, A., Raveendran, J., Onumah, K., Mehta, R. S., White, S., Kasimu-Graham, J., & D’Antonio, P. (n.d.). An Introduction to the Biochemistry & Pharmacology of Medical Cannabis. Washington DC; Department of Health. https://doh.dc.gov/sites/default/files/dc/sites/doh/publication/attachments/Medical%20Cannabis%20An%20Introduction%20to%20the%20Biochemistry%20and%20Pharmacology.pdf
3. Grove, J. (2020, January 14). Do cannabis suppositories work? Project CBD. Retrieved December 7, 2021, from https://www.projectcbd.org/medicine/do-cannabis-suppositories-work
4. Hammell, D. C., Zhang, L. P., Ma, F., Abshire, S. M., McIlwrath, S. L., Stinchcomb, A. L., & Westlund, K. N. (2016). Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. European journal of pain (London, England), 20(6), 936–948. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/
5. Huestis M. A. (2007). Human cannabinoid pharmacokinetics. Chemistry & biodiversity, 4(8), 1770–1804. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/
6. Patra, J. K., Das, G., Fraceto, L. F., Campos, E., Rodriguez-Torres, M., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., Habtemariam, S., & Shin, H. S. (2018). Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology, 16(1), 71. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145203/
7. Karschner, E. L., Darwin, W. D., Goodwin, R. S., Wright, S., & Huestis, M. A. (2011). Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration. Clinical chemistry, 57(1), 66–75. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717338/
8. Millar, S. A., Stone, N. L., Yates, A. S., & O’Sullivan, S. E. (2018). A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. Frontiers in pharmacology, 9, 1365. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275223/
9. Wana Quick Fast-Acting Tincture’s innovative nano-liposomal emulsion technology transforms cannabis consumption. Quicksilver Scientific. (2020, December 1). Retrieved April 7, 202 from https://www.quicksilverscientific.com/wana-quick-fast-acting-tinctures-innovative-nano-liposomal-emulsion-technology-transforms-cannabis-consumption/
10. Perlin, E., Smith, C. G., Nichols, A. I., Almirez, R., Flora, K. P., Cradock, J. C., & Peck, C. C. (1985). Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey. Journal of pharmaceutical sciences, 74(2), 171–174. https://pubmed.ncbi.nlm.nih.gov/2985774/
Sign up for our newsletter
Get your medical marijuana card today
Sign up in under 5 minutes
Start By Selecting Your State